When looking at geopolitics, the macro-view is often the point of view take, looking at all factors that may sway any individuals’ decisions. However, sometimes the micro-view may also have an impact on people and their actions, therefore, they must also be look at; more specifically, genes and manipulations. Genetic engineering and new mutations have developed, and because of this, agriculture is benefiting the most. The United States is currently at the top of the list as far as agricultural biotechnology, but other countries such as China will be trying to become a world, leader.
Agricultural biotechnology uses genetic engineering to pass on only the best traits to newer crops. In addition, the undesirable traits are not passed on. This began in the 1990’s when desirable DNA was intertwined with that of new plants; the term “genetically modified organism,” or GMO, was coined among the food community. Genetic engineering has evolved tremendously since its origin, and now focuses on traits that boost nitrogen intake and promote drought resistance. This evolution was led by constant learning of various play genomes and the ability to manipulate them. Many gene-edited crops are set to enter North America as soon as 2016. Because the U.S. is the leader in genetic manipulation, and rulings have been favorable by the Department of Agriculture, gene-edited crops may enter the market sooner than previously expected.
Europe, on the other hand, has not had the most favorable rulings on gene-edited crops up to now. Therefore, the commercialization will likely be put on a hiatus. This does not mean that there will be absolutely no work being done; the industrial biotechnology sector of Europe has established itself and seeking to increaser environment friendliness within the industry, industrial biotechnology is likely to advance towards the advancement of gene-editing commercialization and marketing in Europe.
Furthermore, China’s growing agricultural biotechnology sector will likely fully implement the techniques. Chinese experiments have already shown less hesitation to try gene editing in human cells. Despite this, the United States will stay at the top of the genetic-engineering movement. Nothing more than just the amount of patents to the field will make it tough for any nation to supersede Washington as a world leader in agricultural biotechnology.